Volker Wacheck

3PUBLICATIONS
17CO-AUTHORS
Molecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 08, 2024
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients.

Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse

|Apr 01, 2022
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.

Christopher J Sweeney, Ivor J Percent, Sunil Babu

Pageof 1